Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-02-24

    Virtual Booth

    Contact Supplier

    Menu

    Prednisone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 814Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr. Reddy lab`s Generics Prednisone Receives Tentative Approval in US
    Dr. Reddy lab`s Generics Prednisone Receives Tentative Approval in US

    08 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218035

    FDA
    08 Aug 2024
    Share Share
    Vincerx Announces Compelling Efficacy of Enitociclib with Venetoclax
    Vincerx Announces Compelling Efficacy of Enitociclib with Venetoclax

    07 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/07/2805016/0/en/Vincerx-Pharma-Announces-Compelling-Clinical-Efficacy-of-Enitociclib-in-Combination-with-Venetoclax-and-Prednisone-in-Lymphoma.html

    GLOBENEWSWIRE
    07 Jan 2024
    Share Share
    FDA approves J&J's PARP combo drug Akeega for prostate cancer
    FDA approves J&J's PARP combo drug Akeega for prostate cancer

    12 Aug 2023

    // FDA

    https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-niraparib-and-abiraterone-acetate-plus-prednisone-brca-mutated-metastatic-castration?utm_medium=email&utm_source=govdelivery#:~:text=On%20August%2011%2C%202023%2C%20the,as%20determined%20by%20an%20FDA%2D

    FDA
    12 Aug 2023
    Share Share
    Health Canada approves Lynparza with abiraterone for patients with BRCA mCRPC
    Health Canada approves Lynparza with abiraterone for patients with BRCA mCRPC

    14 Jul 2023

    // BIOSPACE

    https://www.biospace.com/article/releases/health-canada-approves-lynparza-in-combination-with-abiraterone-and-prednisone-or-prednisolone-for-patients-with-brca-mutated-metastatic-castration-resistant-prostate-cancer/

    BIOSPACE
    14 Jul 2023
    Share Share
    Ibrutinib Plus Chemoimmunotherapy Fails to Improve PFS in Pretreated FL, MZL
    Ibrutinib Plus Chemoimmunotherapy Fails to Improve PFS in Pretreated FL, MZL

    20 Jun 2023

    // Caroline Seymour ONCLIVE

    https://www.onclive.com/view/ibrutinib-plus-chemoimmunotherapy-fails-to-improve-pfs-in-pretreated-follicular-lymphoma-mzl

    Caroline Seymour ONCLIVE
    20 Jun 2023
    Share Share
    US FDA panel backs restricted use of AstraZeneca's prostate cancer drug
    US FDA panel backs restricted use of AstraZeneca's prostate cancer drug

    02 May 2023

    // BUSINESS-STANDARD

    https://www.business-standard.com/world-news/us-fda-panel-backs-restricted-use-of-astrazeneca-s-prostate-cancer-drug-123050100632_1.html

    BUSINESS-STANDARD
    02 May 2023
    Share Share